Vaccine acceptancePregnant persons are at higher risk of severe COVID-19. Although vaccination is recommended, COVID-19 vaccination rates are lower among pregnant persons compared to the non-pregnant population.
Editor’s Picks Current statistics on this topic Diseases Coronavirus (COVID-19) cases, recoveries, and deaths worldwide as of May 2, 2023 Prevention COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023 Diseases New cases of COVID-19 worldwide from January 23...
Due to the challenges of developing a vaccine for SARS-CoV-2, it will likely take another year or more until the public is sufficiently protected from COVID-19 (Lurie et al., 2020). Therefore, it is important to monitor the spread of the disease systematically, anticipate or detect new ...
A safe and effective vaccine is a critical tool to control the COVID-19 pandemic. As of 25 June 2021, 23 vaccines had advanced to Stage 3 clinical trials1and more than a dozen had been approved in multiple countries2. The BNT162b vaccine from Pfizer–BioNTech, for example, has been app...
\({\delta }_{i,t}\) is the proportion of vaccinated individuals, and \({e}_{t}\) is the population-level vaccine effectiveness, which remains the same across states but may change in simulations to capture the effect of new variants. We fit the SIR model above with state-level CO...
Over Boos, Columbia University President Notes Mahmoud Khalil's Absence at Graduation The head of Columbia University alluded to the detention of Palestinian activist Mahmoud Khalil during a commencement speech Wednesday that drew loud boos and chants of “free Palestine” from graduating students ...
Olga Orduna, 46, receives her second coronavirus disease (COVID-19) vaccine at a back-to-school clinic in South Gate, Los Angeles, California, U.S., August 12, 2021. REUTERS/Lucy Nicholson (Reuters) - The United States has administered 353,859,894 doses of COVID-19 vacc...
Find the most relevant statistics and facts on coronavirus (COVID-19): impact on tech goods & services
Second, as more vaccine is distributed and administered, more individuals will be protected against symptomatic infection and the IFR will decrease. Finally, our model does not represent reinfection, either through waning immunity or immune escape; however, reinfection has been documented24,25, ...
government pulled funding for the late-stage study for Inovio's vaccine as other COVID-19 vaccines were already available in the country. Inovio then started late-stage trials outside the United States in partnership with China's Advaccine Biopharmaceuticals. The company is c...